BioSig Technologies, Inc. STEX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$462.78M-4,380% | -$10.33M+64.4% | -$29.04M-7.4% | -$27.05M+15.2% | ||
| -$67.56M-433% | -$12.67M+55.0% | -$28.15M-4.4% | -$26.97M+18.8% | ||
| -$71.1M-453% | -$12.86M+54.9% | -$28.51M-4.6% | -$27.27M+18.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
